MP26-16 RACIAL AND ECONOMIC DISPARITIES IN THE USE OF NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH UROTHELIAL MUSCLE INVASIVE BLADDER CANCER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details